303 related articles for article (PubMed ID: 17584107)
1. Influence of statin use on endothelial function: from bench to clinics.
Martínez-González J; Badimon L
Curr Pharm Des; 2007; 13(17):1771-86. PubMed ID: 17584107
[TBL] [Abstract][Full Text] [Related]
2. Effects of statins on endothelium and their contribution to neovascularization by mobilization of endothelial progenitor cells.
Walter DH; Zeiher AM; Dimmeler S
Coron Artery Dis; 2004 Aug; 15(5):235-42. PubMed ID: 15238818
[TBL] [Abstract][Full Text] [Related]
3. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells.
Thum T; Fraccarollo D; Galuppo P; Tsikas D; Frantz S; Ertl G; Bauersachs J
Cardiovasc Res; 2006 Apr; 70(1):50-60. PubMed ID: 16480696
[TBL] [Abstract][Full Text] [Related]
5. Endothelial dysfunction in heart failure.
Bauersachs J; Widder JD
Pharmacol Rep; 2008; 60(1):119-26. PubMed ID: 18276993
[TBL] [Abstract][Full Text] [Related]
6. The role of endothelial progenitor cells and statins in endothelial function: a review.
Gómez-Cerezo JF; Pagán-Muñoz B; López-Rodríguez M; Estébanez-Muñoz M; Barbado-Hernández FJ
Cardiovasc Hematol Agents Med Chem; 2007 Oct; 5(4):265-72. PubMed ID: 17979688
[TBL] [Abstract][Full Text] [Related]
7. Beyond lipid-lowering: effects of statins on endothelial nitric oxide.
Laufs U
Eur J Clin Pharmacol; 2003 Mar; 58(11):719-31. PubMed ID: 12634978
[TBL] [Abstract][Full Text] [Related]
8. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species.
Wassmann S; Laufs U; Bäumer AT; Müller K; Ahlbory K; Linz W; Itter G; Rösen R; Böhm M; Nickenig G
Hypertension; 2001 Jun; 37(6):1450-7. PubMed ID: 11408394
[TBL] [Abstract][Full Text] [Related]
9. Adverse balance of nitric oxide/peroxynitrite in the dysfunctional endothelium can be reversed by statins.
Heeba G; Hassan MK; Khalifa M; Malinski T
J Cardiovasc Pharmacol; 2007 Oct; 50(4):391-8. PubMed ID: 18049306
[TBL] [Abstract][Full Text] [Related]
10. Direct vascular effects of HMG-CoA reductase inhibitors.
Laufs U; Liao JK
Trends Cardiovasc Med; 2000 May; 10(4):143-8. PubMed ID: 11239793
[TBL] [Abstract][Full Text] [Related]
11. The effects of HMG-CoA reductase inhibitors on endothelial function.
Tesfamariam B
Am J Cardiovasc Drugs; 2006; 6(2):115-20. PubMed ID: 16555864
[TBL] [Abstract][Full Text] [Related]
12. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase.
Landmesser U; Engberding N; Bahlmann FH; Schaefer A; Wiencke A; Heineke A; Spiekermann S; Hilfiker-Kleiner D; Templin C; Kotlarz D; Mueller M; Fuchs M; Hornig B; Haller H; Drexler H
Circulation; 2004 Oct; 110(14):1933-9. PubMed ID: 15466656
[TBL] [Abstract][Full Text] [Related]
13. A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action.
Sumi D; Hayashi T; Thakur NK; Jayachandran M; Asai Y; Kano H; Matsui H; Iguchi A
Atherosclerosis; 2001 Apr; 155(2):347-57. PubMed ID: 11254905
[TBL] [Abstract][Full Text] [Related]
14. Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress.
Mason RP; Walter MF; Jacob RF
Circulation; 2004 Jun; 109(21 Suppl 1):II34-41. PubMed ID: 15173061
[TBL] [Abstract][Full Text] [Related]
15. Effects of statins on endothelium and endothelial progenitor cell recruitment.
Walter DH; Dimmeler S; Zeiher AM
Semin Vasc Med; 2004 Nov; 4(4):385-93. PubMed ID: 15861319
[TBL] [Abstract][Full Text] [Related]
16. Cerivastatin potentiates nitric oxide release and enos expression through inhibition of isoprenoids synthesis.
Kalinowski L; Dobrucki IT; Malinski T
J Physiol Pharmacol; 2002 Dec; 53(4 Pt 1):585-95. PubMed ID: 12512694
[TBL] [Abstract][Full Text] [Related]
17. Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities.
Thomas SR; Witting PK; Drummond GR
Antioxid Redox Signal; 2008 Oct; 10(10):1713-65. PubMed ID: 18707220
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Aberrant MicroRNA-133a Expression in Endothelial Cells by Statin Prevents Endothelial Dysfunction by Targeting GTP Cyclohydrolase 1 in Vivo.
Li P; Yin YL; Guo T; Sun XY; Ma H; Zhu ML; Zhao FR; Xu P; Chen Y; Wan GR; Jiang F; Peng QS; Liu C; Liu LY; Wang SX
Circulation; 2016 Nov; 134(22):1752-1765. PubMed ID: 27765794
[TBL] [Abstract][Full Text] [Related]
19. Rho GTPases, statins, and nitric oxide.
Rikitake Y; Liao JK
Circ Res; 2005 Dec; 97(12):1232-5. PubMed ID: 16339495
[TBL] [Abstract][Full Text] [Related]
20. Acute activation of eNOS by statins involves scavenger receptor-B1, G protein subunit Gi, phospholipase C and calcium influx.
Datar R; Kaesemeyer WH; Chandra S; Fulton DJ; Caldwell RW
Br J Pharmacol; 2010 Aug; 160(7):1765-72. PubMed ID: 20649578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
